Loading company…
Protuoso Bio develops multifunctional protein architectures for complex diseases.
Protuoso Bio develops MUXBODIES™, multifunctional protein architectures created through protein engineering and synthetic biology. Its pipeline includes programs in cardiometabolic disease, oncology, and autoimmune diseases. Based in San Carlos, US, the company raised USD 9.5 mn in seed funding in May 2026, co-led by Taya Venture Capital and Darwin Ventures, with participation from NSG Ventures and SEEDS.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in